Physician profile
Amy Powell
NPI 1093220535
$1,378.43
in general payments reported to CMS, 2019-2025
17 companies · $61.25 in 2025
The $61.25 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $458 · 2022: $410 · 2023: $164 · 2024: $284 · 2025: $61.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $333.15 | 2021-2022 | |
| Viiv Healthcare Company | $275.27 | 2022-2025 | Dovato |
| Boston Scientific Corporation | $169.31 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Daiichi Sankyo INC. | $147.59 | 2021-2024 | Injectafer |
| Collegium Pharmaceutical, INC. | $75.79 | 2021-2023 | Belbuca |
| Biohaven Pharmaceuticals, INC. | $59.95 | 2021 | |
| Ferring Pharmaceuticals INC. | $58.46 | 2024 | Rebyota |
| Eisai INC. | $53.47 | 2023-2024 | |
| Abbvie INC. | $43.42 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.99 | 2022 | |
| Redhill Biopharma INC. | $23.69 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $20.15 | 2021 | |
| Braeburn INC. | $19.93 | 2024 | Brixadi |
| Scilex Pharmaceuticals INC. | $18.58 | 2021 | |
| Misonix INC | $16.75 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $16.24 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.